Study Phase 3

Phase III Study of Pharos Vitesse Neurovascular Stent System Compared to Best Medical Therapy for the Treatment of Ischemic Disease

Trial Information

Generic NameN/AProduct NameVitesse Intracranial StentTherapeutic AreaNervous System DiseasesEnrollment125% Female34.2%% White72%
Product ClassNeurovascular deviceSponsor Protocol NumberVISSIT CA-2007-01Data PartnerJohnson & JohnsonCondition StudiedIschemic StrokeMean/Median Age (Years)61.8

Supporting Documentation

  • Collected Datasets Available
  • Protocol with Amendments Available

Approved Data Requests Associated with this Trial


Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.